{'fraction_non_alphanumeric': 0.028708133971291867, 'fraction_numerical': 0.049441786283891544, 'mean_word_length': 5.541666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fog.

The scientific community is responding to coronavirus disease-2019 (COVID-19) at an unprecedented speed, openly sharing biomedical knowledge, educational initiatives, and clinical studies. Over 35 000 COVID-19 articles have been referenced in PubMed since the first New England Journal of Medicine COVID-19 report on 24 January 2020. Moreover, approximately 7000 preprints have appeared on the medRxiv and bioRxiv platforms. Cardiological journals have published many important articles on COVID-19 cardiovascular implications.